How OS Therapies Succeeds By Putting Patients First
52:51
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
17:12
How A Family Friend’s Illness Inspired The Launch Of OS Therapies
14:31
What’s Next For Adaptimmune?
51:49
Optimizing Lentiviral Purification: Enhancing Chromatography With Monoliths
1:02:35
Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.
1:03:51
Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski
31:15
Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rakhit
11:36